Seres Therapeutics Inc (MCRB)

$9.51 0.00 (N/A)
Market Cap 83.05M
Revenue (ttm) 0.00
Net Income (ttm) 140,000.00
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 100,300
Avg Vol 114,013
Day's Range N/A - N/A
Shares Out 8.73M
Stochastic %K 90%
Beta 2.62
Analysts Sell
Price Target $13.33

Company Profile

Seres Therapeutics, Inc., a clinical-stage company, focuses on developing biotherapeutics for serious diseases. The company develops SER-155, an investigational oral live biotherapeutic to decolonize gastrointestinal pathogens, enhance epithelial barrier integrity, and regulate immune response to prevent bacterial bloodstream infections, as well as other pathogen-associated negative clinical outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation. Its other pipeline pr...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 945 9626
Address:
101 Cambridgepark Drive, Cambridge, United States
jow18
jow18 Jun. 26 at 11:57 PM
$MCRB nice rebound
0 · Reply
TotalChamp
TotalChamp Jun. 26 at 9:24 PM
$MCRB come on baby! Get that momentum back and keep this thing going. Almost got enough confidence to start averaging down again.
0 · Reply
BioCrazy1
BioCrazy1 Jun. 26 at 7:57 PM
$MCRB Can a cup and handle form in a day? The entire pattern can also form within minutes or days. Technical analysts watching the cup-and-handle pattern try to buy when the price breaks out from the handle. This is marked by when the price moves above the old resistance level, which is the top of the right side of the cup.
0 · Reply
BioCrazy1
BioCrazy1 Jun. 26 at 7:50 PM
$MCRB Didn't see that coming.
0 · Reply
RB818
RB818 Jun. 26 at 7:42 PM
$MCRB News has to be very close as regards FDA, make no mistake. Any day now. And with the low float after the reverse split, it can get crazy to the upside when news hits.
1 · Reply
Bulltrader988
Bulltrader988 Jun. 26 at 7:20 PM
$MCRB Eric we are waiting for some news 👃👀
0 · Reply
EC100
EC100 Jun. 26 at 7:00 PM
$MCRB turning green?
1 · Reply
Rawbinhood
Rawbinhood Jun. 26 at 5:51 PM
$MCRB Low volume pull back, before the run!!!
0 · Reply
BioCrazy1
BioCrazy1 Jun. 26 at 4:38 PM
$MCRB All the penny flippers that jumped in yesterday are jumping out today. Good riddance.
1 · Reply
Tritsortreat2020
Tritsortreat2020 Jun. 26 at 4:28 PM
$MCRB when you play with crooks, you gotta play by their books . our time is near
0 · Reply
Latest News on MCRB
Seres Therapeutics Presents Expanded SER-155 Exploratory Biomarker Data at 2025 ASCO Annual Meeting

May 27, 2025, 7:00 AM EDT - 4 weeks ago

Seres Therapeutics Presents Expanded SER-155 Exploratory Biomarker Data at 2025 ASCO Annual Meeting

Seres Therapeutics, Inc. (MCRB) Q1 2025 Earnings Call Transcript

May 7, 2025, 2:18 PM EDT - 7 weeks ago

Seres Therapeutics, Inc. (MCRB) Q1 2025 Earnings Call Transcript

Seres Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Updates

May 7, 2025, 7:00 AM EDT - 7 weeks ago

Seres Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Updates

Seres Therapeutics Presents Data at the 2025 Digestive Disease Week Conference Highlighting the Potential for Live Biotherapeutics to Treat Inflammatory and Immune Diseases

Apr 29, 2025, 7:00 AM EDT - 2 months ago

Seres Therapeutics Presents Data at the 2025 Digestive Disease Week Conference Highlighting the Potential for Live Biotherapeutics to Treat Inflammatory and Immune Diseases

Seres Therapeutics to Announce First Quarter 2025 Financial Results and Business Updates on May 7, 2025

Apr 23, 2025, 7:00 AM EDT - 2 months ago

Seres Therapeutics to Announce First Quarter 2025 Financial Results and Business Updates on May 7, 2025

Seres Therapeutics, Inc. (MCRB) Q4 2024 Earnings Call Transcript

Mar 13, 2025, 11:04 AM EDT - 3 months ago

Seres Therapeutics, Inc. (MCRB) Q4 2024 Earnings Call Transcript

Seres Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

Mar 13, 2025, 7:00 AM EDT - 3 months ago

Seres Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

Seres Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 13, 2025

Mar 4, 2025, 7:00 AM EST - 4 months ago

Seres Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 13, 2025

Seres Therapeutics Receives Feedback From FDA on SER-155 Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) Development Approach

Mar 3, 2025, 7:00 AM EST - 4 months ago

Seres Therapeutics Receives Feedback From FDA on SER-155 Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) Development Approach

Seres Therapeutics Announces Receipt of Expected $50 Million Installment Payment Related to VOWST Sale

Jan 16, 2025, 7:00 AM EST - 5 months ago

Seres Therapeutics Announces Receipt of Expected $50 Million Installment Payment Related to VOWST Sale

Seres Therapeutics Announces New Translational Biomarker Results from SER-155 Phase 1b Clinical Study and Provides Corporate Updates

Jan 9, 2025, 7:00 AM EST - 6 months ago

Seres Therapeutics Announces New Translational Biomarker Results from SER-155 Phase 1b Clinical Study and Provides Corporate Updates

Seres Therapeutics to Participate in 2025 J.P. Morgan Healthcare Conference

Dec 16, 2024, 7:00 AM EST - 6 months ago

Seres Therapeutics to Participate in 2025 J.P. Morgan Healthcare Conference

Seres Therapeutics to Participate in Piper Sandler Healthcare Conference

Nov 22, 2024, 7:00 AM EST - 7 months ago

Seres Therapeutics to Participate in Piper Sandler Healthcare Conference

Seres Therapeutics, Inc. (MCRB) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 10:28 AM EST - 8 months ago

Seres Therapeutics, Inc. (MCRB) Q3 2024 Earnings Call Transcript

Seres Therapeutics to Announce Third Quarter 2024 Financial Results and Business Updates on November 13, 2024

Nov 6, 2024, 7:00 AM EST - 8 months ago

Seres Therapeutics to Announce Third Quarter 2024 Financial Results and Business Updates on November 13, 2024

Seres Therapeutics Announces Completion of VOWST™ Asset Sale to Société des Produits Nestlé S.A

Sep 30, 2024, 5:15 PM EDT - 9 months ago

Seres Therapeutics Announces Completion of VOWST™ Asset Sale to Société des Produits Nestlé S.A

Seres Therapeutics Stockholders Issue Open Letter to Board of Directors Regarding Reported Engagement With Nestlé

Sep 27, 2024, 3:26 PM EDT - 9 months ago

Seres Therapeutics Stockholders Issue Open Letter to Board of Directors Regarding Reported Engagement With Nestlé

Seres Therapeutics Stockholders Approve Sale of VOWST™ to Nestlé Health Science; Sale Expected to Close on September 30

Sep 26, 2024, 4:01 PM EDT - 9 months ago

Seres Therapeutics Stockholders Approve Sale of VOWST™ to Nestlé Health Science; Sale Expected to Close on September 30

Seres Therapeutics' Strategic Sale Of Vowst Warrants A Rating Upgrade

Sep 23, 2024, 12:14 AM EDT - 9 months ago

Seres Therapeutics' Strategic Sale Of Vowst Warrants A Rating Upgrade

Seres Therapeutics to Participate in Cantor 2024 Global Healthcare Conference

Sep 13, 2024, 7:00 AM EDT - 10 months ago

Seres Therapeutics to Participate in Cantor 2024 Global Healthcare Conference

Seres Therapeutics Reports SER-155 Phase 1b Placebo-Controlled Cohort 2 Study Safety and Clinical Results in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT)

Sep 12, 2024, 7:00 AM EDT - 10 months ago

Seres Therapeutics Reports SER-155 Phase 1b Placebo-Controlled Cohort 2 Study Safety and Clinical Results in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT)

Seres Therapeutics, Inc. (MCRB) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 3:35 PM EDT - 11 months ago

Seres Therapeutics, Inc. (MCRB) Q2 2024 Earnings Call Transcript

Seres Therapeutics to Announce Second Quarter 2024 Financial Results and Business Update on August 13, 2024

Aug 6, 2024, 7:00 AM EDT - 11 months ago

Seres Therapeutics to Announce Second Quarter 2024 Financial Results and Business Update on August 13, 2024

Seres Therapeutics Announces Signing of VOWST™ Asset Purchase Agreement with Nestlé Health Science

Aug 6, 2024, 7:00 AM EDT - 11 months ago

Seres Therapeutics Announces Signing of VOWST™ Asset Purchase Agreement with Nestlé Health Science

Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jun 7, 2024, 4:00 PM EDT - 1 year ago

Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Nestlé Health Science agrees to acquire global rights to VOWST®, product it launched in June 2023

Jun 6, 2024, 7:00 AM EDT - 1 year ago

Nestlé Health Science agrees to acquire global rights to VOWST®, product it launched in June 2023

Seres Therapeutics Enters Into Memorandum of Understanding For Vowst™ Asset Sale to Nestlé Health Science

Jun 6, 2024, 6:30 AM EDT - 1 year ago

Seres Therapeutics Enters Into Memorandum of Understanding For Vowst™ Asset Sale to Nestlé Health Science

Seres Therapeutics, Inc. (MCRB) Q1 2024 Earnings Call Transcript

May 11, 2024, 5:34 PM EDT - 1 year ago

Seres Therapeutics, Inc. (MCRB) Q1 2024 Earnings Call Transcript

Seres Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

May 8, 2024, 7:00 AM EDT - 1 year ago

Seres Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

Seres Therapeutics to Announce First Quarter 2024 Financial Results and Business Update on May 8, 2024

May 6, 2024, 9:30 AM EDT - 1 year ago

Seres Therapeutics to Announce First Quarter 2024 Financial Results and Business Update on May 8, 2024

Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT

Apr 9, 2024, 7:00 AM EDT - 1 year ago

Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT

VKTX, JANX and these biotech stocks are surging in 2024

Apr 2, 2024, 2:10 AM EDT - 1 year ago

VKTX, JANX and these biotech stocks are surging in 2024

ARQT JANX VKTX AMLX RAPT RVNC

Seres Therapeutics, Inc. (MCRB) Q4 2023 Earnings Call Transcript

Mar 5, 2024, 3:33 PM EST - 1 year ago

Seres Therapeutics, Inc. (MCRB) Q4 2023 Earnings Call Transcript

Seres Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates

Mar 5, 2024, 7:00 AM EST - 1 year ago

Seres Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates

Seres Therapeutics to Host Fourth Quarter 2023 Financial Results and Operational Progress Conference Call and Webcast on March 5, 2024

Feb 28, 2024, 7:00 AM EST - 1 year ago

Seres Therapeutics to Host Fourth Quarter 2023 Financial Results and Operational Progress Conference Call and Webcast on March 5, 2024

Seres Therapeutics to Participate in Cowen 44th Annual Healthcare Conference

Feb 27, 2024, 7:00 AM EST - 1 year ago

Seres Therapeutics to Participate in Cowen 44th Annual Healthcare Conference

Seres Therapeutics Announces the Appointment of Marella Thorell as Chief Financial Officer and the Retirement of David Arkowitz

Feb 26, 2024, 7:00 AM EST - 1 year ago

Seres Therapeutics Announces the Appointment of Marella Thorell as Chief Financial Officer and the Retirement of David Arkowitz

Seres Therapeutics Announces VOWST™ Commercial Launch Update and US FDA Fast Track Designation for SER-155

Jan 9, 2024, 7:00 AM EST - 1 year ago

Seres Therapeutics Announces VOWST™ Commercial Launch Update and US FDA Fast Track Designation for SER-155

Seres Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Jan 4, 2024, 4:00 PM EST - 1 year ago

Seres Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Seres Therapeutics Announces Presentation of Preliminary PK/PD and Safety Data for Investigational Microbiome Therapeutic SER-155 at ASH 2023

Dec 7, 2023, 7:46 PM EST - 1 year ago

Seres Therapeutics Announces Presentation of Preliminary PK/PD and Safety Data for Investigational Microbiome Therapeutic SER-155 at ASH 2023

Seres Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023; Webcast at 3:30 p.m. ET

Nov 28, 2023, 9:18 AM EST - 1 year ago

Seres Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023; Webcast at 3:30 p.m. ET

Seres Therapeutics, Inc. (MCRB) Q3 2023 Earnings Call Transcript

Nov 4, 2023, 11:52 AM EDT - 1 year ago

Seres Therapeutics, Inc. (MCRB) Q3 2023 Earnings Call Transcript

Seres Therapeutics Reports Third Quarter 2023 Financial Results Including VOWST™ Net Sales of $7.6 Million

Nov 2, 2023, 7:00 AM EDT - 1 year ago

Seres Therapeutics Reports Third Quarter 2023 Financial Results Including VOWST™ Net Sales of $7.6 Million

Seres Therapeutics to Announce Third Quarter 2023 Results on Thursday, November 2, 2023; Host Conference Call and Webcast at 8:00 a.m. EST

Oct 30, 2023, 5:30 PM EDT - 1 year ago

Seres Therapeutics to Announce Third Quarter 2023 Results on Thursday, November 2, 2023; Host Conference Call and Webcast at 8:00 a.m. EST

Seres Therapeutics to Highlight VOWST™ Data at IDWeek

Oct 12, 2023, 7:00 AM EDT - 1 year ago

Seres Therapeutics to Highlight VOWST™ Data at IDWeek

Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development Officer

Sep 11, 2023, 6:30 AM EDT - 1 year ago

Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development Officer

DNLI FHTX MRNA SANA

Seres Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

Sep 7, 2023, 10:00 AM EDT - 1 year ago

Seres Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

Seres Therapeutics: Approved Drug And Nestle Partnership Make It A Buy

Sep 1, 2023, 2:03 PM EDT - 1 year ago

Seres Therapeutics: Approved Drug And Nestle Partnership Make It A Buy

Seres Therapeutics, Inc. (MCRB) Q2 2023 Earnings Call Transcript

Aug 8, 2023, 3:03 PM EDT - 2 years ago

Seres Therapeutics, Inc. (MCRB) Q2 2023 Earnings Call Transcript

jow18
jow18 Jun. 26 at 11:57 PM
$MCRB nice rebound
0 · Reply
TotalChamp
TotalChamp Jun. 26 at 9:24 PM
$MCRB come on baby! Get that momentum back and keep this thing going. Almost got enough confidence to start averaging down again.
0 · Reply
BioCrazy1
BioCrazy1 Jun. 26 at 7:57 PM
$MCRB Can a cup and handle form in a day? The entire pattern can also form within minutes or days. Technical analysts watching the cup-and-handle pattern try to buy when the price breaks out from the handle. This is marked by when the price moves above the old resistance level, which is the top of the right side of the cup.
0 · Reply
BioCrazy1
BioCrazy1 Jun. 26 at 7:50 PM
$MCRB Didn't see that coming.
0 · Reply
RB818
RB818 Jun. 26 at 7:42 PM
$MCRB News has to be very close as regards FDA, make no mistake. Any day now. And with the low float after the reverse split, it can get crazy to the upside when news hits.
1 · Reply
Bulltrader988
Bulltrader988 Jun. 26 at 7:20 PM
$MCRB Eric we are waiting for some news 👃👀
0 · Reply
EC100
EC100 Jun. 26 at 7:00 PM
$MCRB turning green?
1 · Reply
Rawbinhood
Rawbinhood Jun. 26 at 5:51 PM
$MCRB Low volume pull back, before the run!!!
0 · Reply
BioCrazy1
BioCrazy1 Jun. 26 at 4:38 PM
$MCRB All the penny flippers that jumped in yesterday are jumping out today. Good riddance.
1 · Reply
Tritsortreat2020
Tritsortreat2020 Jun. 26 at 4:28 PM
$MCRB when you play with crooks, you gotta play by their books . our time is near
0 · Reply
db4
db4 Jun. 26 at 4:22 PM
$MCRB interesting news from today apparently Nestle is not alone! https://www.linkedin.com/posts/the-microbiome-times_danone-further-invests-in-next-generation-activity-7343898847774937088-vhpg?utm_medium=ios_app&rcm=ACoAAAaD33EBlM5JdywDBBWlpyXt_4bNPS8tpLI&utm_source=social_share_send&utm_campaign=messages
1 · Reply
mktfixer
mktfixer Jun. 26 at 4:22 PM
$MCRB No news we lose
0 · Reply
Whitenoise27
Whitenoise27 Jun. 26 at 3:47 PM
$MCRB makes sense to me. As expected
0 · Reply
LionNoRichy
LionNoRichy Jun. 26 at 3:46 PM
$MCRB tc
0 · Reply
investhedge
investhedge Jun. 26 at 2:53 PM
$MCRB shares short 679 k as of 6/13 , compared to 798k as of 5/15 , those bastards are covering slowly, but nice reduction of 20% almost
1 · Reply
Tritsortreat2020
Tritsortreat2020 Jun. 26 at 1:17 PM
$MCRB lets get some follow through today crafty shafty
0 · Reply
BioCrazy1
BioCrazy1 Jun. 26 at 10:32 AM
$MCRB This guy had his face ripped off!
0 · Reply
Whitenoise27
Whitenoise27 Jun. 25 at 10:52 PM
$MCRB when you’re in for a small short
1 · Reply
Tritsortreat2020
Tritsortreat2020 Jun. 25 at 10:25 PM
$MCRB 4 million bilune today (presplit) 🤙
1 · Reply
TheBurnerAccount
TheBurnerAccount Jun. 25 at 10:17 PM
$SPY $QQQ $NVDA $TSLA Anytime you see the mcrib $MCRB tending, you know you're near a market top.
1 · Reply
Rawbinhood
Rawbinhood Jun. 25 at 9:50 PM
$MCRB Thanks for your insight @TheContrarianOne , let us know what price you plan to cover your small short position!!!
1 · Reply
jacksparo
jacksparo Jun. 25 at 9:31 PM
I am working on a new important updates to share with my vip team via the email most likely this weekend about $ALT Another new update about $AKBA New chart zone for AKBA and what might happen in July 2025! $BB After the great earning for this one where it might be headed next! $MCRB Entered a new zone and it is important to know what all the possible moves here in the coming two weeks! Stay tuned for another great email from Jack!
1 · Reply